Peng‐Cheng Lv

959 citations
26 papers · 858 indexed · h-index 16
Topics
Synthesis and biological activity (15 papers)Synthesis and Biological Evaluation (6 papers)Cancer therapeutics and mechanisms (5 papers)

In The Last Decade

Peng‐Cheng Lv

26 papers receiving 830 citations

Peers

Peng‐Cheng Lv
Comparison fields: 5 of 67
  • Organic Chemistry 684
  • Molecular Biology 247
  • Pharmacology 91
  • Oncology 88
  • Computational Theory and Mathematics 78
Replace Soad A. El-Hawash with:
Soad A. El-Hawash Egypt
G. Bharath Kumar India
Nadia S. El‐Gohary Egypt
Hayam M. A. Ashour Egypt
Farid M. Sroor Egypt
Ahsan Ahmed Khan India
Zulphikar Ali India
Vunnam Srinivasulu United Arab Emirates
Elshimaa M. N. Abdelhafez Egypt
Şeref Demirayak Türkiye
Peng‐Cheng Lv relative to Soad A. El-Hawash Egypt Soad A. El-Hawash's profile →
Citations per field
00.5×1.5×1.8×
Soad A. El-Hawash · 1×
Citations per year

Countries citing papers authored by Peng‐Cheng Lv

Since Specialization
Citations

This map shows the geographic impact of Peng‐Cheng Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng‐Cheng Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng‐Cheng Lv more than expected).

Fields of papers citing papers by Peng‐Cheng Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng‐Cheng Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng‐Cheng Lv. The network helps show where Peng‐Cheng Lv may publish in the future.

Co-authorship network of co-authors of Peng‐Cheng Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Peng‐Cheng Lv. A scholar is included among the top collaborators of Peng‐Cheng Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng‐Cheng Lv. Peng‐Cheng Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 35
2 16
3 24
4 26
5 25
6 14
7 29
8 32
9 20
10 13
11 62
12 28
13 244
14 17
15 78
16 35
17 1
18 14
19 14
20 13

About Peng‐Cheng Lv

Peng‐Cheng Lv is a scholar working on Toxicology, Organic Chemistry and Oncology, having authored 26 papers that have together received 858 indexed citations. Recurring topics across this work include Synthesis and biological activity (15 papers), Synthesis and Biological Evaluation (6 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Organic Chemistry (684 citations), Toxicology (68 citations) and Pharmacology (91 citations). Peng‐Cheng Lv has collaborated with scholars based in China, United States and Ireland. Frequent co-authors include Hai‐Liang Zhu, Juan Sun, Huan‐Qiu Li, Yang Zhou, Yong Yin, Mark Cushman, Yves Pommier, Christophe Marchand, Keli Agama and Mingzhu Zhang. Their work appears in journals such as PLoS ONE, Journal of Medicinal Chemistry and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026